Regenica plans to develop a vector platform to generate cutting-edge vaccines to protect against tier-1 select biological threats. This platform has generated potent immunological responses against:

  • Anthrax

  • Tularemia

  • Pneumonic Plague

  • Glanders

  • Melioidosis

Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from Youtube
Consent to display content from Vimeo
Google Maps
Consent to display content from Google